Article

CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes…

Disease Markers · 2017 · Carlotta Raschioni, author Giulia Bottai, author Andrea Sagona, author Valentina Errico, author Alberto Testori, author Wolfgang Gatzemeier, author Fabio Corsi, author Corrado Tinterri, author Massimo Roncalli, author Libero Santarpia, author Luca Di Tommaso, author Alvaro González, Academic Editor

Key facts

Title CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression
First author Carlotta Raschioni, author Giulia Bottai, author Andrea Sagona, author Valentina Errico, author Alberto Testori, author Wolfgang Gatzemeier, author Fabio Corsi, author Corrado Tinterri, author Massimo Roncalli, author Libero Santarpia, author Luca Di Tommaso, author Alvaro González, Academic Editor
Journal Disease Markers
Published Sep 28, 2017
DOI 10.1155/2018/5018671
Product codes mentioned JCC, JJH, KIR, MVU, NJT, PPM

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature